Post-injection delirium/sedation syndrome after treatment with olanzapine depot

Autor: Mohammad, Milan, Alaoui-Ismaili, Zakaria, Baandrup, Lone, Barzanji, Ayob Farouk
Jazyk: dánština
Rok vydání: 2023
Předmět:
Zdroj: Mohammad, M, Alaoui-Ismaili, Z, Baandrup, L & Barzanji, A F 2023, ' Postinjektionssyndrom efter behandling med olanzapin depot ', Ugeskrift for Laeger, bind 185, nr. 19, V02230069 . < https://ugeskriftet.dk/videnskab/postinjektionssyndrom-efter-behandling-med-olanzapin-depot >
Popis: Treatment with olanzapine depot is associated with a rare but potentially adverse reaction, namely post-injection delirium/sedation syndrome (PDSS), characterized by delirium and/or sedation. This is a case report of a 38-year-old male patient who developed symptoms consistent with PDSS shortly after receiving intramuscular injection of olanzapine depot. Clinicians should be aware of PDSS and observe patients for three hours after receiving the injection, measuring vitals and referring to medical care if necessary. Treatment with olanzapine depot is associated with a rare but potentially adverse reaction, namely post-injection delirium/sedation syndrome (PDSS), characterized by delirium and/or sedation. This is a case report of a 38-year-old male patient who developed symptoms consistent with PDSS shortly after receiving intramuscular injection of olanzapine depot. Clinicians should be aware of PDSS and observe patients for three hours after receiving the injection, measuring vitals and referring to medical care if necessary.
Databáze: OpenAIRE